EA201890312A1 - Применение ингибиторов il-8 в лечении некоторых урологических расстройств - Google Patents

Применение ингибиторов il-8 в лечении некоторых урологических расстройств

Info

Publication number
EA201890312A1
EA201890312A1 EA201890312A EA201890312A EA201890312A1 EA 201890312 A1 EA201890312 A1 EA 201890312A1 EA 201890312 A EA201890312 A EA 201890312A EA 201890312 A EA201890312 A EA 201890312A EA 201890312 A1 EA201890312 A1 EA 201890312A1
Authority
EA
Eurasian Patent Office
Prior art keywords
inhibitors
treatment
compositions
application
urological disorders
Prior art date
Application number
EA201890312A
Other languages
English (en)
Inventor
Марселло Аллегретти
Андреа Арамини
Мария Кандида Цеста
Жанлука Бианчини
Лаура Брандолини
Патриция Ангелико
Original Assignee
Домпе Фармачеутичи С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Домпе Фармачеутичи С.П.А. filed Critical Домпе Фармачеутичи С.П.А.
Publication of EA201890312A1 publication Critical patent/EA201890312A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Заявленное изобретение относится к применению соединений, содержащих ингибиторы IL-8, предпочтительно ингибиторы двойных рецепторов CXCR1/CXCR2, в лечении и/или профилактике интерстициального цистита / синдрома раздраженного мочевого пузыря (ИЦ/СРМП) и/или сверхактивного мочевого пузыря (СМП), также включая ИЦ/СРМП и/или СМП, вызванные противораковой терапией. Целью заявленного изобретения также являются способы лечения и/или профилактики, композиции и комбинации, включающие упомянутые композиции, а также составы, содержащие упомянутые ингибиторы IL-8.
EA201890312A 2015-07-14 2016-07-12 Применение ингибиторов il-8 в лечении некоторых урологических расстройств EA201890312A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15176726.6A EP3117835A1 (en) 2015-07-14 2015-07-14 Il-8 inhibitors for use in the treatment of certain urological disorders
PCT/EP2016/066511 WO2017009323A1 (en) 2015-07-14 2016-07-12 Il-8 inhibitors for use in the treatment of certain urological disorders

Publications (1)

Publication Number Publication Date
EA201890312A1 true EA201890312A1 (ru) 2018-08-31

Family

ID=53757997

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201890312A EA201890312A1 (ru) 2015-07-14 2016-07-12 Применение ингибиторов il-8 в лечении некоторых урологических расстройств
EA202190242A EA202190242A1 (ru) 2015-07-14 2016-07-12 Применение ингибиторов il-8 в лечении некоторых урологических нарушений

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA202190242A EA202190242A1 (ru) 2015-07-14 2016-07-12 Применение ингибиторов il-8 в лечении некоторых урологических нарушений

Country Status (25)

Country Link
US (1) US20180200231A1 (ru)
EP (2) EP3117835A1 (ru)
JP (1) JP6937738B2 (ru)
KR (1) KR102622924B1 (ru)
CN (1) CN107921105B (ru)
AU (1) AU2016292902B2 (ru)
BR (1) BR112018000676A2 (ru)
CA (1) CA2991810A1 (ru)
CY (1) CY1125437T1 (ru)
DK (1) DK3322438T3 (ru)
EA (2) EA201890312A1 (ru)
ES (1) ES2894077T3 (ru)
HR (1) HRP20211574T1 (ru)
HU (1) HUE056439T2 (ru)
IL (1) IL256413B (ru)
LT (1) LT3322438T (ru)
MA (1) MA42437A (ru)
MD (1) MD3322438T2 (ru)
MX (1) MX2018000539A (ru)
PL (1) PL3322438T3 (ru)
PT (1) PT3322438T (ru)
RS (1) RS62413B1 (ru)
SI (1) SI3322438T1 (ru)
WO (1) WO2017009323A1 (ru)
ZA (1) ZA201708608B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3342407A1 (en) * 2017-01-03 2018-07-04 Dompé farmaceutici S.p.A. Il-8 inihibitors for use in the treatment of some urological disorders
CN114712377B (zh) * 2022-04-26 2023-08-15 江苏师范大学 断血流皂苷a在制造药物中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025157A1 (en) * 1995-02-17 1996-08-22 Smithkline Beecham Corporation Il-8 receptor antagonists
EP1776336B1 (en) 2004-03-23 2009-09-30 DOMPE' pha.r.ma s.p.a. 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
EP2166006A1 (en) * 2008-09-18 2010-03-24 Dompe' S.P.A. 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
WO2010078403A2 (en) 2008-12-30 2010-07-08 Lipella Pharmaceuticals Inc. Methods and compositions for diagnosing urological disorders
KR101458947B1 (ko) * 2013-03-05 2014-11-12 국립암센터 인터루킨-８ 앱타머 및 이의 용도

Also Published As

Publication number Publication date
ES2894077T3 (es) 2022-02-11
EA202190242A1 (ru) 2021-11-30
HUE056439T2 (hu) 2022-02-28
WO2017009323A1 (en) 2017-01-19
MD3322438T2 (ro) 2022-01-31
RS62413B1 (sr) 2021-10-29
EP3117835A1 (en) 2017-01-18
DK3322438T3 (da) 2021-10-18
LT3322438T (lt) 2021-10-25
JP2018520184A (ja) 2018-07-26
KR20180030075A (ko) 2018-03-21
KR102622924B1 (ko) 2024-01-09
MX2018000539A (es) 2018-09-06
ZA201708608B (en) 2019-05-29
BR112018000676A2 (pt) 2018-09-18
PL3322438T3 (pl) 2022-01-03
CN107921105B (zh) 2022-08-02
JP6937738B2 (ja) 2021-09-22
IL256413B (en) 2021-04-29
AU2016292902A1 (en) 2018-01-18
AU2016292902B2 (en) 2021-06-03
PT3322438T (pt) 2021-10-01
US20180200231A1 (en) 2018-07-19
HRP20211574T1 (hr) 2022-02-04
EP3322438A1 (en) 2018-05-23
SI3322438T1 (sl) 2021-11-30
NZ739077A (en) 2023-12-22
EP3322438B1 (en) 2021-09-08
CN107921105A (zh) 2018-04-17
MA42437A (fr) 2021-06-02
IL256413A (en) 2018-02-28
CA2991810A1 (en) 2017-01-19
CY1125437T1 (el) 2023-03-24

Similar Documents

Publication Publication Date Title
EA202092590A1 (ru) Пиридазиноны в качестве ингибиторов parp7
EA201792028A1 (ru) Альфа-цинамидные соединения и композиции как ингибиторы hdac8
EA201891910A1 (ru) Гетероарильные ингибиторы pad4
EA201790806A1 (ru) Иммунорегулирующие средства
EA201792205A1 (ru) Гетероциклические соединения как ингибиторы lsd1
EA201992878A1 (ru) Соединения для лечения болезни хантингтона
EA201890111A1 (ru) Замещенные производные оксопиридина
EA201791836A1 (ru) 1-(гет)арилсульфонил-(пирролидин или пиперидин)-2-карбоксамидные производные и их применение в качестве антагонистов trpa1
EA201790737A1 (ru) Комбинированная терапия
EA201991183A1 (ru) Новые ингибиторы глутаминазы
EA201892008A1 (ru) Соединения и способы лечения неврологических и сердечно-сосудистых состояний
EA201991720A1 (ru) Антитела к альфа-синуклеину и их применения
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EA201790688A1 (ru) Новые соединения в качестве ингибиторов nik
EA201790817A1 (ru) 2-амино-3,5-дифтор-3,6-диметил-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы bace1 для лечения болезни альцгеймера
EA201692049A1 (ru) Гетероарилзамещенные гетероциклилсульфоны
EA201890185A1 (ru) Способы лечения опосредованных гепсидином нарушений
EA201790519A1 (ru) Терапевтические соединения в качестве ингибиторов рецептора орексина-1
EA202090183A1 (ru) Композиции, способы и получение дейтерированного домперидона
EA201790908A1 (ru) Новые производные тиенопиримидина в качестве ингибиторов nik
EA201790818A1 (ru) 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы bace1
EA201692313A1 (ru) Производные индолизина в качестве ингибиторов фосфоинозитид-3-киназ
EA201790904A1 (ru) Новые производные пиразола в качестве ингибиторов nik
EA201991600A1 (ru) СОЕДИНЕНИЯ, МОДУЛИРУЮЩИЕ АРИЛУГЛЕВОДОРОДНЫЙ РЕЦЕПТОР (AhR)
EA201790907A1 (ru) Новые производные пиразолопиримидина в качестве ингибиторов nik